Previously, we also found that mitochondrial inhibitors, such as carbonylcyanide p-trifluoromethoxyphenylhydrazone (FCCP), can destabilize MYC/MYCN and suppress the growth of NB cells (7), suggesting the potential use of mitochondrial inhibitors in the treatment of NB. The gene discussed is MYC; the disease is neuroblastoma.